Cargando…
P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171697/ http://dx.doi.org/10.1097/01.HS9.0000936364.16730.66 |
| _version_ | 1785039478372433920 |
|---|---|
| author | Duminuco, A. Romano, A. Leotta, D. La Spina, E. Cambria, D. Bulla, A. Del Fabro, V. Tibullo, D. Giallongo, C. Palumbo, G.A. Conticello, C. Di Raimondo, F. |
| author_facet | Duminuco, A. Romano, A. Leotta, D. La Spina, E. Cambria, D. Bulla, A. Del Fabro, V. Tibullo, D. Giallongo, C. Palumbo, G.A. Conticello, C. Di Raimondo, F. |
| author_sort | Duminuco, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171697 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101716972023-05-11 P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA Duminuco, A. Romano, A. Leotta, D. La Spina, E. Cambria, D. Bulla, A. Del Fabro, V. Tibullo, D. Giallongo, C. Palumbo, G.A. Conticello, C. Di Raimondo, F. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171697/ http://dx.doi.org/10.1097/01.HS9.0000936364.16730.66 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Duminuco, A. Romano, A. Leotta, D. La Spina, E. Cambria, D. Bulla, A. Del Fabro, V. Tibullo, D. Giallongo, C. Palumbo, G.A. Conticello, C. Di Raimondo, F. P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA |
| title | P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA |
| title_full | P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA |
| title_fullStr | P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA |
| title_full_unstemmed | P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA |
| title_short | P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA |
| title_sort | p59 active treatment and low igm are associated with inferior sars-cov-2 spike antibody response to three doses of covid-19 rna vaccination in patients with multiple myeloma |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171697/ http://dx.doi.org/10.1097/01.HS9.0000936364.16730.66 |
| work_keys_str_mv | AT duminucoa p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT romanoa p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT leottad p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT laspinae p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT cambriad p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT bullaa p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT delfabrov p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT tibullod p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT giallongoc p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT palumboga p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT conticelloc p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma AT diraimondof p59activetreatmentandlowigmareassociatedwithinferiorsarscov2spikeantibodyresponsetothreedosesofcovid19rnavaccinationinpatientswithmultiplemyeloma |